Figure 6.KEGG Enrichment and therapeutic targets of ADCYs in AML. (A) Significant terms among the gene memberships (Metascape). (B) KEGG analysis of FANGs in AML. (C) Protein-drug interaction map for inhibitors of the MAPK pathway in AML.
Figure 6 — Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia | Aging
